FEDERATED HERMES, INC. - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 67 filers reported holding ONCOCYTE CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q4 2022$1,147
-42.6%
3,574
+47.7%
0.00%
Q3 2022$2,000
+100.0%
2,420
+417.1%
0.00%
Q1 2020$1,000
-98.8%
468
-98.7%
0.00%
Q4 2019$81,00036,0270.00%
Other shareholders
ONCOCYTE CORP shareholders Q2 2020
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 1,093,219$6,833,0001.15%
HUNTINGTON NATIONAL BANK 10$00.00%
CITIGROUP INC 642$4,0000.00%
Sonora Investment Management, LLC 50$00.00%
BARCLAYS PLC 206$1,0000.00%
BLACKROCK ADVISORS LLC 96$1,0000.00%
View complete list of ONCOCYTE CORP shareholders